文献速递放疗物理与技术胸部肿瘤放疗消化道肿瘤放疗

采用新型环形机架对上腹部或下胸部靶区进行体表运动门控立体定向体部放疗的可行性试验

A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry.
PubMed 文献 · Clin Transl Radiat Oncol · 2023-10-23

这项前瞻性试验纳入10例需接受立体定向体部放疗(SBRT)且能屏气至少17秒的上腹部或下胸部肿瘤患者,采用新型环形机架、光学体表运动监测门控(±2 mm容差)和屏气技术分5次照射。51次计划分次中47次(92%)成功门控,63%的分次进行了在线计划自适应,中位总治疗时间78.5分钟;3个月后未观察到局部复发或急性≥3级毒性。

要点

  • 51次SBRT分次中47次(92%)通过光学体表运动监测在屏气状态下成功门控。
  • 屏气期间肿瘤质心位置平均变化约2 mm。
  • 63%的分次进行了在线计划自适应,中位总治疗时间78.5分钟。

核心结论

  • 在新型环形机架上采用体表监测门控对上腹部或下胸部移动靶区进行SBRT治疗已获得前瞻性验证。

研究设计与样本

  • 前瞻性可行性试验(NCT05030454),纳入10例处方SBRT至胸部或腹部靶区且能屏气至少17秒的患者。
  • 患者接受5次SBRT,采用屏气技术和光学体表运动监测门控,容差为±2 mm。
  • 在线计划自适应由当日治疗医师酌情决定。
  • 主要终点为成功完成超过75%的尝试分次;探索性终点包括3个月后的局部控制和急性≥3级毒性率。
  • 对自适应分次记录勾画、计划、质量保证和治疗实施时间。

主要发现

  • 51次SBRT分次中47次(92%)通过光学体表运动监测在屏气状态下成功门控。
  • 屏气期间肿瘤质心位置平均变化约2 mm。
  • 63%的分次进行了在线计划自适应,中位总治疗时间为78.5分钟。
  • 3个月后未观察到局部复发或急性≥3级毒性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A novel O-ring gantry can deliver stereotactic body radiation therapy (SBRT) with artificial intelligence-facilitated, CT-guided online plan adaptation. It gates mobile targets by optically monitoring skin surface motion. However, this gating solution has not been clinically validated. We conducted a trial to evaluate the feasibility of optical skin surface-guided gating for patients with mobile upper abdominal or lower thoracic malignancies treated with SBRT on this platform (NCT05030454). MATERIALS AND METHODS: Ten patients who were prescribed SBRT to a thoracic or abdominal target and were capable of breath-hold for at least 17 s enrolled. They received SBRT in five fractions with breath-hold technique and optical skin surface motion monitored-gating with a ± 2 mm tolerance. Online plan adaptation was left to the discretion of the daily treating physician. The primary endpoint was defined as successful completion of > 75 % of attempted fractions. Exploratory endpoints included local control and acute grade ≥ 3 toxicity rates after three months. For adapted fractions the contouring, planning, quality assurance, and treatment delivery times were recorded. RESULTS: Forty-seven of 51 SBRT fractions (92 %) were successfully gated at breath-hold by optical skin surface motion monitoring. The tumor centroid position during breath-hold varied by a mean of approximately 2 mm. Sixty-three percent of fractions were adapted online with a median total treatment time of 78.5 min. After three months no local recurrences or acute grade ≥ 3 toxicities were observed. CONCLUSIONS: SBRT treatment to mobile targets with surface-monitored gating on a novel O-ring gantry was prospectively validated.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kiser K, Schiff J, Laugeman E, et al. A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2023. PMID: 38021090. doi:10.1016/j.ctro.2023.100692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。